- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Genetics Research International
Volume 2014 (2014), Article ID 318304, 10 pages
Expression of Potential Regulatory Genes in Abdominal Adipose Tissue of Broiler Chickens during Early Development
1College of Agriculture, Human and Natural Science, Tennessee State University, Nashville, TN 37209, USA
2Department of Biological Sciences, Tennessee State University, 3500 John A. Merritt Bou Levard, Nashville, TN 37209, USA
Received 31 July 2013; Accepted 7 November 2013; Published 16 January 2014
Academic Editor: Urs Albrecht
Copyright © 2014 Ann Bohannon-Stewart et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The identities of genes that underlie population variation in adipose tissue development in farm animals are poorly understood. Previous studies in our laboratory have suggested that increased fat tissue involves the expression modulation of an array of genes in broiler chickens. Of special interest are eight genes, FGFR3, EPHB2, IGFBP2, GREM1, TNC, COL3A1, ACBD7, and SCD. To understand their expression regulation and response to dietary manipulation, we investigated their mRNA levels after dietary manipulation during early development. Chickens were fed either a recommended standard or a high caloric diet from hatch to eight weeks of age (WOA). The high caloric diet markedly affected bodyweight of the broiler birds. mRNA levels of the eight genes in the abdominal adipose tissue were assayed at 2, 4, 6, and 8 WOA using RT-qPCR. Results indicate that (1) FGFR3 mRNA level was affected significantly by diet, age, and diet:age interaction; (2) COL3A mRNA level was repressed by high caloric diet; (3) mRNA levels of EPHB2, ACBD7, and SCD were affected by age; (4) mRNA level of TNC was modulated by age:diet interaction; (5) changes in GREM1 and IGFBP2 mRNA levels were not statistically different.
In chickens, quantitative trait loci (QTL) mapping studies have identified a number of loci in fat deposition [1–7]. In different mapping populations, the loci that contribute to fat deposition appear to be unique because different chicken strains inherited a unique set of alleles. Since QTL mapping studies are often conducted in F2 crosses or backcrosses, which have limited chromosomal crossovers, they often end up with broad chromosomal regions in which hundreds of candidate genes may potentially be responsible for the fat QTL. The identities of genes or regulatory elements for the inferred traits are thus unknown. On the other hand, candidate genes are often evaluated through association studies using DNA sequence variations such as single nucleotide polymorphism (SNP) and short tandem repeats [8–12]. Various alleles of quite a few of the evaluated genes were shown to increase fat deposition.
During early development, the chicken adipose tissue grows by both hyperplasia and hypertrophy [13, 14]. Hyperplasia depends on the proliferation of preadipocytes, since mature adipocytes do not multiply. Although there are few studies on preadipocyte proliferation in chickens [15–19], it is generally believed that its mechanism would be similar to that in mammals and other vertebrates, as almost all genes that play key roles in mammals are also found in the chicken. For example, lipogenic transcription factors such as PPARg and CCAAT/enhancer binding proteins are clearly expressed in the chicken preadipocytes and have similar roles in lipogenesis [15, 17, 19] as in other species. Many growth factors have also been shown to regulate adipocyte proliferation in chickens . At least a portion of the genes involved in preadipocyte hyperplasia are also involved in adipocyte hypertrophy. PPARg not only induces preadipocyte proliferation and differentiation but also stimulate lipogenic gene expression in adipocytes .
There are obvious differences between mammalian and avian adipose tissues. The chicken does not have GLUT4, the major protein that transports glucose across the plasma membrane in response to insulin. Thus, other glucose transporters must be in place of GLUT4 . The synthesis of fatty acids takes place predominantly in the liver, with adipocytes contributing a small portion of fatty acid synthesis to the stored lipids , which is in sharp contrast to that in many mammals. It is largely questionable as to whether there is a leptin gene in the chicken , although the chicken leptin receptor does exist and can be experimentally demonstrated .
Numerous gaps exist in our knowledge regarding chicken adipose tissue development, particularly the molecular events that lead to differential fat deposition given the same feeding. We have previously studied gene expression in adipose tissue of chickens fed the same ration with similar bodyweight but differential abdominal fat weights and fat percentages. This study revealed a number of differentially expressed genes in abdominal fat tissue between fat and lean chickens (reported separately). It is of special interest to evaluate the regulatory mechanisms of these differentially expressed genes so that their roles and regulatory mechanisms in fat deposition are better understood. Here, we have selected a group of the differential genes that likely play a regulatory role or are target of regulation in different metabolic or development status. The selected genes include four encoding signaling proteins (FGFR3 encoding fibroblast growth factor receptor 3, EPHB2 encoding ephrin type-B receptor 2, GREM1 encoding gremlin 1, and IGFBP2 encoding insulin-like growth factor binding protein 2), two extracellular matrix genes (COL3A1 encoding collagen, type III, alpha 1, and TNC encoding cytotactin or tenascin-C), and two metabolic genes (ACBD7 encoding acyl-CoA-binding domain containing 7 and SCD encoding stearoyl-CoA desaturase). We hypothesize that these genes are regulated either by nutritional factors or by developmental programming in chickens. To test this hypothesis, broiler chickens were treated with a high caloric diet (HCD) or recommended standard diet (RSD) for 8 weeks; then mRNA levels were analyzed in abdominal fat tissue at 2, 4, 6, and 8 weeks of age (WOA). Here, the results of this study are reported.
2. Materials and Methods
2.1. Animals and Dietary Treatment
New hatched broiler chickens (113 males and 113 females, commercial generation) were purchased from Ideal Poultry (Texas, USA) and reared at Tennessee State University in the Frank A. Young Poultry Research Plant. Birds of each sex were assigned at random to two dietary treatments: RSD or HCD. There were six replicates () for each treatment of each sex. The diets were corn-soy-based. RSD contained 21% crude protein, 3040 kcal/kg of metabolizable energy (ME), formulated per National Research Council recommendations for broiler chickens. HCD contained 23% crude protein, 3340 ME, formulated based on preliminary experimental rations designed to induce obesity in growing broilers. The use of animals was approved by Tennessee State University Institutional Animal Care and Use Committee (IACUC).
All birds were weighed weekly. At 2, 4, 6, and 8 WOA, one chicken from each replicate was sacrificed. Samples of abdominal fat pad and fat around the gizzard were collected, weighed, placed in liquid nitrogen for direct freeze, and then transferred to −80°C until RNA isolation.
2.2. RNA Isolation and RT-qPCR
Abdominal adipose RNA of male chickens ( per age group) was extracted with RNeasy Lipid Tissue Midi kit (Qiagen). RNA concentrations were measured with a NanoDrop spectrophotometer (NanoDrop Technologies, Wilmington, DE). All samples were analyzed with Experion RNA StdSens analysis kit to determine the quality. PCR primers were designed using Primer Express 2.0 (Applied Biosystems; see Table 1 for primer information). All RT-qPCR assays were conducted using QuantiTect SYBR Green RT-PCR kit (Qiagen). Reaction was done in 20 μL containing 50 ng of total RNA and 0.4 μM of each primer. Thermal cycles contained one cycle of pre-incubation at 50°C for 10 minutes and 95°C for 15 minutes, 35 cycles of amplification (95°C for 15 seconds and 60°C for 60 seconds). Primers were validated by melting curve analysis, standard curve, and nontemplate control reactions. For standard curve analysis, an RNA pool was made, serial-diluted to 0.08, 0.39, 1.56, 6.25, 25, 50, and 100 ng/μL, and measured again with spectrophotometer. Each concentration was analyzed in duplication with RT-qPCR to determine amplification efficiency.
2.3. Data Analysis
-test was used to compare mean bodyweight between groups. ANOVA and Fisher post hoc test were used to analyze RT-qPCR data.
3.1. Effect of Dietary Treatment on Animal Growth
Birds fed HCD had significantly higher bodyweight () than those fed RSD at 2 through 7 WOA (Figure 1). At 8 WOA, birds fed HCD were still larger than those fed RSD, though not statistically significant, which may be due to the fact that there were fewer birds in each group at this age. At 1 WOA, there were no significant differences between treatments, probably due to not having enough time to accumulate bodyweight.
Bodyweight gain (BWG) for animals that were fed HCD and RSD is presented in Table 2, in which BWG was grouped by sex. Both males and females on HCD established greater gains than their counterparts on RSD. For the male group, birds on HCD gained significantly more weight than those on RSD during weeks 2–5. However, there were no significant differences between the two groups during 6, 7, and 8 WOA. This is interesting in that, in the final two weeks, males on RSD did display higher weight gains than males on HCD. During weeks 2 and 3, females on HCD displayed significantly higher BWG () than females on RSD. A similar result was also observed during week 6. Much like in the males, during the last 2 weeks, there were greater BWG for birds on RSD. The data indicates that the HCD led to an increase in BWG in both sexes.
When different diet groups of the same sex were compared, bodyweights showed no significant difference in both male and female chicks at hatch (Table 3). At 1 and 2 WOA, female birds fed HCD had a higher bodyweight than females fed RSD (). This suggests that the HCD affected the females at an earlier age than the males because the males had no significant differences between diet groups at 1 and 2 WOA. At 3 and 4 WOA, birds fed HCD had a higher bodyweight than those fed RSD () in both males and females. At 5 WOA, males on HCD were heavier that those on RSD with , while females on HCD were also heavier than their counter part on RSD with . At 6 WOA, both males and females fed HCD were significantly different from those fed RSD at . At 7 WOA, males had significant differences at level and females had significant differences between diet groups. At 8 WOA only females had a significant difference at .
When mean bodyweights at the same age on the same diet were compared, males appeared heavier than the females through most ages, though not statistically significant; however, at 3 WOA, the females were heavier than males in both diet groups. At 5 WOA, males on HCD showed a significant difference () over females (Table 3).
3.2. Effect of Dietary Treatment on Abdominal Fat Content
Figure 2 shows comparisons of abdominal fat weights between birds fed RSD and HCD. It appeared that birds fed HCD had accumulated more abdominal fat on average than those fed RSD, though the differences were either statistically marginal or insignificant, likely due to the large variations among individuals. This observation holds true, regardless if males and females were examined separately (Figures 2(b) and 2(c)) or combined (Figure 2(a)). Likely, statistically significant differences in fat deposition between HCD and RSD birds could be demonstrated when more birds are dissected.
When compared between males and females on the same diet, males had significantly more fat tissue than females at 2 WOA on RSD (), as measured in absolute amount (g) and in bodyweight percentage (Figures 3(a) and 3(c)). By 8 WOA, female chickens appeared to have accumulated more abdominal adipose tissue than males when both were fed RSD (Figure 3(a)) and had 12.3 g more than males when both were fed HCD (Figure 3(b)), though the differences were not statistically significant. The differences became statistically significant when fat tissue was calculated as percentage of bodyweight (Figures 3(c) and 3(d)). There were no significant differences in HCD and RSD between sexes at 4 and 6 WOA (Figures 3(a), 3(b), 3(c), and 3(d)).
3.3. Effects of Dietary Treatment and Age on mRNA Levels
Four signaling related genes were examined for mRNA level. FGFR3 displayed significant differences among both age and dietary groups as well as age by diet interaction. At 2 WOA, FGFR3 mRNA was significantly higher than that at 4 and 6 WOA. At 8 WOA, FGFR3 mRNA levels were significantly elevated in birds fed RSD (Figure 4(a)). EPHB2 showed an age-dependent decrease in expression level () from 2 to 6 WOA and then increased at 8 WOA, but diet did not affect EPHB2 expression, nor did the interaction between age and diet (Figure 4(b)). For GREM1 and IGFBP2, dietary treatments did not affect their mRNA level, nor did age (Figures 4(c) and 4(d)).
Two genes encoding extracellular matrix were examined. COL3A1 mRNA showed significant differences between groups fed HCD and RSD () but not among age nor among age by diet interactions. In general, birds fed HCD tend to express less COL3A1 than those fed RSD (Figure 4(e)). TNC expression displayed significant differences in age by diet interaction () but not age nor diet alone (Figure 4(f)).
Two metabolic genes, ACBD7 and SCD, were also examined. ACBD7 showed an age-dependent increase in expression level (), but diet did not affect ACBD7 expression, nor did the interaction between age and diet (Figure 4(g)). SCD showed an age-dependent decrease in expression level () until 8 WOA, but diet did not affect SCD expression, nor did the interaction between age and diet (Figure 4(h)).
In this experiment, birds fed HCD gained significantly greater bodyweight than those fed RSD. Abdominal fat weight in chickens fed the HCD appeared higher than that in chickens fed RSD, though the differences were not significant. Nevertheless, dietary manipulation caused significant phenotypic changes in chickens during the period studied. In terms of gene expression, mRNA levels of three genes were markedly affected by either dietary manipulation (i.e., COL3A1 and FGFR3) or the interaction of dietary manipulation and age (TNC and FGFR3). COL3A1 expression was, in general, reduced in chickens on HCD. The mRNA level of TNC was significantly higher in chickens fed HCD than those fed RSD at 8 weeks of age. In general, dietary manipulation affected chicken growth and fat deposition, at least partially by modulation of FGFR3, COL3A1, and TNC expression.
Among the eight genes examined in this study, five genes, FGFR3, EPHB2, TNC, ACBD7, and SCD, exhibited developmental changes in expression level. FGFR3 mRNA level was decreased from 2 to 4 WOA and then kept approximately steady until 8 WOA when there were significant age by diet interactions (Figure 4(a)). TNC mRNA level was affected as a result of age:diet interaction (Figure 4(f)). EPHB2 mRNA level was first lowered from 2 to 6 WOA and thereafter increased from 6 to 8 WOA. TNC expression displayed an age-dependent response to dietary manipulation. At 8 WOA, chickens fed RSD had significantly lower TNC mRNA level than those fed HCD. The mRNA level of ACBD7 increased steadily and that of SCD decreased steadily during the first 8 weeks of development. These data indicate that developmental programming has the most significant effect on the expression of these genes in chicken adipose tissue. At least during early age, the growth of chicken adipose tissue involves preadipocyte proliferation and size increase. There are many different cell types involved in the remodeling of adipose tissue. Thus, whether the expression changes of these genes occurred in a specific cell type or in all cell types remains to be clarified.
FGFR3 is an important regulator of bone growth and has a strong proliferative effect on cancer (reviewed in ). The role of both FGFR3 and GREM1 in adipose tissue is unknown. Considering their mitogenic activities, it is plausible to assume that these genes are necessary for preadipocyte proliferation and vascular development in adipose tissues. Our assay showed that FGFR3 expression level decreased in the first few weeks. Whether this is associated with reduced adipocyte proliferation remains unclear.
EPHB2 encodes the ephrin B2 receptor, a transmembrane protein involved in signaling . Previous studies on EPHB2 function were mainly focused on its role in tumor growth [27–29] and brain development [30, 31]. To our knowledge, few studies have been conducted regarding EPHB2 in adipose tissue. Our study shows that EPHB2 is expressed in adipose tissue, where likely sources of EPHB2 expression include adipocytes, macrophages, and angiogenic cells. Macrophages and angiogenic cells have been shown to express EPHB2. Adipocytes also express EPHB2, as evidenced by the presence of EPHB2 transcripts in 3T3-L1 adipocytes in the Gene Expression Omnibus database. We found that EPHB2 mRNA level was gradually reduced in chicken adipose tissue during 2–6 WOA and then increased at 8 WOA. The reason for the mRNA level change is not clear. Since adipose tissue growth requires tissue remodeling, EPHB2 may play a role in the remodeling process.
The protein product of GREM1 is required for early limb outgrowth and patterning, particularly in bone growth [32, 33]. It also plays a role in angiogenesis by acting as an agonist of the major angiogenic VEGFR2 . In this study, GREM1 did not show any statistical difference among ages and diet, indicating that it is not regulated by these two factors during this developmental stage in chicken adipose tissue.
IGFBP2 inhibits IGF-mediated growth and developmental rates . IGF-binding proteins prolong the half-life of the IGFs and have been shown to either inhibit or stimulate the growth promoting effects of the IGFs on cell culture. They alter the interaction of IGFs with their cell surface receptors . Studies have shown that IGFBP2 genetic variation is associated with fat deposition in chickens [37–39]. However, the level of IGFBP2 mRNA was unresponsive to diet and was also not affected by age in adipose tissue. The effect of IGFBP2 on adipose tissue development does not involve the direct regulation of IFGBP2 mRNA level in this tissue.
Tenascins and collagens are extracellular matrix proteins. Tenascin-C is a substrate-adhesion molecule in the glycoprotein family . It helps to regulate cell proliferation, adhesion, and migration  in developing embryos. Other reports claim that tenascin-C is predominantly expressed during embryonic development and wound healing . As an essential component of extracellular matrix, collagens not only play a supporting role for adipocytes but also regulate the development of adipose tissue by participating in signaling in mammals. For example, null-collagen VI expression is associated with increased adipose tissue . On the other hand, disruption of collagens V and VI synthesis may cause impaired triglyceride accumulation in adipocytes . Our study showed that COL3A1 expression was altered by dietary manipulation. Birds fed RSD expressed higher levels of COL3A1 mRNA, suggesting that collagen III participates in and regulates the remodeling of adipose tissue in chickens.
ACBD7 is a small 10 KD protein with acyl-CoA-binding (ACB) domain. The ACB domain consists of four alpha-helices arranged in a bowl shape with a highly exposed acyl-CoA-binding site. The ligand is bound through specific interactions with residues on the protein. This is by several conserved positive charges that interact with the phosphate group on the adenosine-3′ phosphate moiety, and the acyl chain is the middle of the hydrophobic surfaces of CoA and the protein . Acyl-CoA-binding protein (ACBP) binds thiol esters of long fatty acids and coenzyme A in a one-to-one binding mode with high specificity and affinity. Acyl-CoAs are reported to play a large role as intermediates in fatty lipid synthesis and fatty acid degradation. Therefore, they play a part in the regulation of intermediary metabolism and gene regulation. The role of ACBP is believed to be an intracellular acyl-CoA transporter and pool former . In our study we found a significant difference in age only, which seems to be a steady increase from 2 to 8 WOA.
In vertebrates SCDs are key enzymes involved in de novo monounsaturated fatty acid synthesis . SCDs are responsible for forming a double bond in stearoyl-CoA. This is how the monounsaturated fatty acid oleic acid is produced from the saturated fatty acid stearic acid. SCD catalyzes a rate-limiting step in the synthesis of unsaturated fatty acids. The principal product of SCD is oleic acid, which is formed by desaturation of stearic acid. The ratio of stearic acid to oleic acid has been implicated in the regulation of cell growth and differentiation through effects on cell membrane fluidity and signal transduction [48–50]. SCDs also generate essential components of phospholipids, triglycerides, cholesterol esters, and wax esters . In chickens, there is much reported evidence that SCD plays a potential role in the control of bodyweight and energy homeostasis, and the expression level of this gene is affected by food deprivation ; however, our study only found a significant difference in age, where SCD mRNA levels were much lower at 4 and 6 WOA than those at 2 and 8 WOA.
The amount of fat deposited in the body is regulated by a large array of factors, including energy composition in food, satiety of animals, and ability of cells to take up energy disposal due to movement. In farm animals, genes that determine population variations in fat deposition are largely unknown. An understanding of how adipose tissue expresses genes would help uncover the determining genes. The genes studied here are all expressed highly in chicken adipose tissue, indicating that they play a role in this tissue through various mechanisms.
Conflict of Interests
The authors declare that there is no conflict of interests regarding the publication of this paper.
Special thanks are due to Rhia Nelson, Shatira Wilson, and Breyonna Jarrett for helping in collecting samples and rearing chicks. This work was supported by USDA Grants (2008-38814-04728, 2011-38821-31025).
- C. O. N. Ikeobi, J. A. Woolliams, D. R. Morrice et al., “Quantitative trait loci affecting fatness in the chicken,” Animal Genetics, vol. 33, no. 6, pp. 428–435, 2002.
- L. Jacobsson, H.-B. Park, P. Wahlberg et al., “Many QTLs with minor additive effects are associated with a large difference in growth between two selection lines in chickens,” Genetical Research, vol. 86, no. 2, pp. 115–125, 2005.
- H.-B. Park, L. Jacobsson, P. Wahlberg, P. B. Siegel, and L. Andersson, “QTL analysis of body composition and metabolic traits in an intercross between chicken lines divergently selected for growth,” Physiological Genomics, vol. 25, no. 2, pp. 216–223, 2006.
- S. Lagarrigue, F. Pitel, W. Carré et al., “Mapping quantitative trait loci affecting fatness and breast muscle weight in meat-type chicken lines divergently selected on abdominal fatness,” Genetics Selection Evolution, vol. 38, no. 1, pp. 85–97, 2006.
- B. Abasht, F. Pitel, S. Lagarrigue et al., “Fatness QTL on chicken chromosome 5 and interaction with sex,” Genetics Selection Evolution, vol. 38, no. 3, pp. 297–311, 2006.
- H. Zhou, N. Deeb, C. M. Evock-Clover, C. M. Ashwell, and S. J. Lamont, “Genome-wide linkage analysis to identify chromosomal regions affecting phenotypic traits in the chicken. I. Growth and average daily gain,” Poultry Science, vol. 85, no. 10, pp. 1700–1711, 2006.
- Z. S. Goraga, M. K. Nassar, and G. A. Brockmann, “Quantitative trait loci segregating in crosses between New Hampshire and White Leghorn chicken lines: I. egg production traits,” Animal Genetics, vol. 43, no. 2, pp. 183–189, 2012.
- X. Wang, W. Carre, H. Zhou, S. J. Lamont, and L. A. Cogburn, “Duplicated Spot 14 genes in the chicken: characterization and identification of polymorphisms associated with abdominal fat traits,” Gene, vol. 332, no. 1-2, pp. 79–88, 2004.
- Q. Wang, H. Li, N. Li, L. Leng, Y. Wang, and Z. Tang, “Identification of single nucleotide polymorphism of adipocyte fatty acid-binding protein gene and its association with fatness traits in the chicken,” Poultry Science, vol. 85, no. 3, pp. 429–434, 2006.
- H. Li, G. Wu, J. Zhang, and N. Yang, “Identification of the heart-type fatty acid-binding protein as a major gene for chicken fatty acid metabolism by bayesian network analysis,” Poultry Science, vol. 89, no. 9, pp. 1825–1833, 2010.
- M. Lei, C. Luo, X. Peng et al., “Polymorphism of growth-correlated genes associated with fatness and muscle fiber traits in chickens,” Poultry Science, vol. 86, no. 5, pp. 835–842, 2007.
- X. L. Zhang, X. Jiang, Y. P. Liu, H. R. Du, and Q. Zhu, “Identification of AvaI polymorphisms in the third intron of GH gene and their associations with abdominal fat in chickens,” Poultry Science, vol. 86, no. 6, pp. 1079–1083, 2007.
- S. C. Butterwith, “Regulators of adipocyte precursor cells,” Poultry Science, vol. 76, no. 1, pp. 118–123, 1997.
- L. Guo, B. Sun, Z. Shang et al., “Comparison of adipose tissue cellularity in chicken lines divergently selected for fatness,” Poultry Science, vol. 90, no. 9, pp. 2024–2034, 2011.
- F. Gondret, P. Ferré, and I. Dugail, “ADD-1/SREBP-1 is a major determinant of tissue differential lipogenic capacity in mammalian and avian species,” Journal of Lipid Research, vol. 42, no. 1, pp. 106–113, 2001.
- Y. Matsubara, K. Sato, H. Ishii, and Y. Akiba, “Changes in mRNA expression of regulatory factors involved in adipocyte differentiation during fatty acid induced adipogenesis in chicken,” Comparative Biochemistry and Physiology A, vol. 141, no. 1, pp. 108–115, 2005.
- Y. Wang, Y. Mu, H. Li et al., “Peroxisome proliferator-activated receptor-γ gene: a key regulator of adipocyte differentiation in chickens,” Poultry Science, vol. 87, no. 2, pp. 226–232, 2008.
- S.-A. Oh, Y. Suh, M.-G. Pang, and K. Lee, “Cloning of avian G(0)/G(1) switch gene 2 genes and developmental and nutritional regulation of G(0)/G(1) switch gene 2 in chicken adipose tissue,” Journal of Animal Science, vol. 89, no. 2, pp. 367–375, 2011.
- H. Cui, G. Zhao, R. Liu, M. Zheng, J. Chen, and J. Wen, “FSH stimulates lipid biosynthesis in chicken adipose tissue by upregulating the expression of its receptor FSHR,” Journal of Lipid Research, vol. 53, no. 5, pp. 909–917, 2012.
- K. Sato, K. Matsushita, Y. Matsubara, T. Kamada, and Y. Akiba, “Adipose tissue fat accumulation is reduced by a single intraperitoneal injection of peroxisome proliferator-activated receptor gamma agonist when given to newly hatched chicks,” Poultry Science, vol. 87, no. 11, pp. 2281–2286, 2008.
- T. Kono, M. Nishida, Y. Nishiki, Y. Seki, K. Sato, and Y. Akiba, “Characterisation of glucose transporter (GLUT) gene expression in broiler chickens,” British Poultry Science, vol. 46, no. 4, pp. 510–515, 2005.
- H. D. Griffin, K. Guo, D. Windsor, and S. C. Butterwith, “Adipose tissue lipogenesis and fat deposition in leaner broiler chickens,” Journal of Nutrition, vol. 122, no. 2, pp. 363–368, 1992.
- F. Pitel, T. Faraut, G. Bruneau, and P. Monget, “Is there a leptin gene in the chicken genome? Lessons from phylogenetics, bioinformatics and genomics,” General and Comparative Endocrinology, vol. 167, no. 1, pp. 1–5, 2010.
- W. Carre, X. Wang, T. E. Porter et al., “Chicken genomics resource: Sequencing and annotation of 35,407 ESTs from single and multiple tissue cDNA libraries and CAP3 assembly of a chicken gene index,” Physiological Genomics, vol. 25, no. 3, pp. 514–524, 2006.
- S. Foldynova-Trantirkova, W. R. Wilcox, and P. Krejci, “Sixteen years and counting: the current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias,” Human Mutation, vol. 33, no. 1, pp. 29–41, 2012.
- M. Vidaurreta, S. Rafael, S. Veganzones et al., “Influence of A9 region mutation in EphB2 gene in the prognosis of patients with colorectal adenocarcinoma,” Annals of Surgical Oncology, vol. 18, no. 5, pp. 1501–1505, 2011.
- A. Chetcuti, S. Aktas, N. Mackie et al., “Expression profiling reveals MSX1 and EphB2 expression correlates with the invasion capacity of Wilms tumors,” Pediatric Blood and Cancer, vol. 57, no. 6, pp. 950–957, 2011.
- B. P. Fox and R. P. Kandpal, “A paradigm shift in EPH receptor interaction: biological relevance of EPHB6 interaction with EPHA2 and EPHB2 in breast carcinoma cell lines,” Cancer Genomics and Proteomics, vol. 8, no. 4, pp. 185–193, 2011.
- Y. Tu, S. He, J. Fu et al., “Expression of EphrinB2 and EphB4 in glioma tissues correlated to the progression of glioma and the prognosis of glioblastoma patients,” Clinical and Translational Oncology, vol. 14, no. 3, pp. 214–220, 2012.
- S. D. Karam, R. C. Burrows, C. Logan, S. Koblar, E. B. Pasquale, and M. Bothwell, “Eph receptors and ephrins in the developing chick cerebellum: relationship to sagittal patterning and granule cell migration,” Journal of Neuroscience, vol. 20, no. 17, pp. 6488–6500, 2000.
- E. Bouche, M. I. Romero-Ortega, M. Henkemeyer et al., “Reelin induces EphB activation,” Cell Research, vol. 23, no. 4, pp. 473–490, 2013.
- E. Gazzerro, R. C. Pereira, V. Jorgetti, S. Olson, A. N. Economides, and E. Canalis, “Skeletal overexpression of gremlin impairs bone formation and causes osteopenia,” Endocrinology, vol. 146, no. 2, pp. 655–665, 2005.
- E. Gazzerro, A. Smerdel-Ramoya, S. Zanotti et al., “Conditional deletion of gremlin causes a transient increase in bone formation and bone mass,” Journal of Biological Chemistry, vol. 282, no. 43, pp. 31549–31557, 2007.
- S. Mitola, C. Ravelli, E. Moroni et al., “Gremlin is a novel agonist of the major proangiogenic receptor VEGFR2,” Blood, vol. 116, no. 18, pp. 3677–3680, 2010.
- S. Rajaram, D. J. Baylink, and S. Mohan, “Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions,” Endocrine Reviews, vol. 18, no. 6, pp. 801–831, 1997.
- D. Chesik, J. De Keyser, and N. Wilczak, “Insulin-like growth factor binding protein-2 as a regulator of IGF actions in CNS: implications in multiple sclerosis,” Cytokine and Growth Factor Reviews, vol. 18, no. 3-4, pp. 267–278, 2007.
- M. M. Lei, Q. H. Nie, X. Peng, D. X. Zhang, and X. Q. Zhang, “Single nucleotide polymorphisms of the chicken insulin-like factor binding protein 2 gene associated with chicken growth and carcass traits,” Poultry Science, vol. 84, no. 8, pp. 1191–1198, 2005.
- Z. H. Li, H. Li, H. Zhang, S. Z. Wang, Q. G. Wang, and Y. X. Wang, “Identification of a single nucleotide polymorphism of the insulin-like growth factor binding protein 2 gene and its association with growth and body composition traits in the chicken,” Journal of Animal Science, vol. 84, no. 11, pp. 2902–2906, 2006.
- L. Leng, S. Wang, Z. Li, Q. Wang, and H. Li, “A polymorphism in the 3′-flanking region of insulin-like growth factor binding protein 2 gene associated with abdominal fat in chickens,” Poultry Science, vol. 88, no. 5, pp. 938–942, 2009.
- A. L. Prieto, G. M. Edelman, and K. L. Crossin, “Multiple integrins mediate cell attachment to cytotactin/tenascin,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 21, pp. 10154–10158, 1993.
- R. P. Tucker, K. Drabikowski, J. F. Hess, J. Ferralli, R. Chiquet-Ehrismann, and J. C. Adams, “Phylogenetic analysis of the tenascin gene family: evidence of origin early in the chordate lineage,” BMC Evolutionary Biology, vol. 6, article 60, 2006.
- G. Orend, W. Huang, M. A. Olayioye, N. E. Hynes, and R. Chiquet-Ehrismann, “Tenascin-C blocks cell-cycle progression of anchorage-dependent fibroblasts on fibronectin through inhibition of syndecan-4,” Oncogene, vol. 22, no. 25, pp. 3917–3926, 2003.
- T. Khan, E. S. Muise, P. Iyengar et al., “Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI,” Molecular and Cellular Biology, vol. 29, no. 6, pp. 1575–1591, 2009.
- I. Nakajima, S. Muroya, R.-I. Tanabe, and K. Chikuni, “Positive effect of collagen V and VI on triglyceride accumulation during differentiation in cultures of bovine intramuscular adipocytes,” Differentiation, vol. 70, no. 2-3, pp. 84–91, 2002.
- M. Burton, T. M. Rose, N. J. Færgeman, and J. Knudsen, “Evolution of the acyl-CoA binding protein (ACBP),” Biochemical Journal, vol. 392, no. 2, pp. 299–307, 2005.
- J. Knudsen, T. B. Neergaard, B. Gaigg, M. V. Jensen, and J. K. Hansen, “Role of acyl-CoA binding protein in acyl-CoA metabolism and acyl-CoA-mediated cell signaling,” Journal of Nutrition, vol. 130, no. 2, supplement, pp. 294S–298S, 2000.
- L. F. C. Castro, J. M. Wilson, O. Gonçalves, S. Galante-Oliveira, E. Rocha, and I. Cunha, “The evolutionary history of the stearoyl-CoA desaturase gene family in vertebrates,” BMC Evolutionary Biology, vol. 11, no. 1, article 132, 2011.
- L. Zhang, L. Ge, S. Parimoo, K. Stenn, and S. M. Prouty, “Human stearoyl-CoA desaturase: alternative transcripts generated from a single gene by usage of tandem polyadenylation sites,” Biochemical Journal, vol. 340, no. 1, pp. 255–264, 1999.
- J. Li, S.-F. Ding, N. A. Habib, B. F. Fermor, C. B. Wood, and R. S. Gilmour, “Partial characterization of a cDNA for human stearoyl-CoA desaturase and changes in its mRNA expression in some normal and malignant tissues,” International Journal of Cancer, vol. 57, no. 3, pp. 348–352, 1994.
- J. Wang, L. Yu, R. E. Schmidt et al., “Characterization of HSCD5, a novel human stearoyl-CoA desaturase unique to primates,” Biochemical and Biophysical Research Communications, vol. 332, no. 3, pp. 735–742, 2005.
- S. Dridi, M. Taouis, A. Gertler, E. Decuypere, and J. Buyse, “The regulation of stearoyl-CoA desaturase gene expression is tissue specific in chickens,” Journal of Endocrinology, vol. 192, no. 1, pp. 229–236, 2007.